-
1
-
-
23744500093
-
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
-
Lehrman G, Hogue IB, Palmer S, Jennings C, Spina CA, Wiegand A, Landay AL, Coombs RW, Richman DD, Mellors JW, Coffin JM, Bosch RJ, Margolis DM. 2005. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366:549-555. http://dx.doi.org/10.1016 /S0140-6736(05)67098-5.
-
(2005)
Lancet
, vol.366
, pp. 549-555
-
-
Lehrman, G.1
Hogue, I.B.2
Palmer, S.3
Jennings, C.4
Spina, C.A.5
Wiegand, A.6
Landay, A.L.7
Coombs, R.W.8
Richman, D.D.9
Mellors, J.W.10
Coffin, J.M.11
Bosch, R.J.12
Margolis, D.M.13
-
2
-
-
77949592502
-
+cell infection
-
+cell infection. PLoS One 5:e9390. http://dx.doi.org/10.1371/journal .pone.0009390.
-
(2010)
PLoS One
, vol.5
-
-
Archin, N.M.1
Cheema, M.2
Parker, D.3
Wiegand, A.4
Bosch, R.J.5
Coffin, J.M.6
Eron, J.7
Cohen, M.8
Margolis, D.M.9
-
3
-
-
50949131800
-
+ T cells
-
+ T cells. AIDS 22:1131-1135. http://dx .doi.org/10.1097/QAD.0b013e3282fd6df4.
-
(2008)
AIDS
, vol.22
, pp. 1131-1135
-
-
Archin, N.M.1
Eron, J.J.2
Palmer, S.3
Hartmann-Duff, A.4
Martinson, J.A.5
Wiegand, A.6
Bandarenko, N.7
Schmitz, J.L.8
Bosch, R.J.9
Landay, A.L.10
Coffin, J.M.11
Margolis, D.M.12
-
4
-
-
84864203255
-
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
-
Archin NM, Liberty AL, Kashuba AD, Choudhary SK, Kuruc JD, Crooks AM, Parker DC, Anderson EM, Kearney MF, Strain MC, Richman DD, Hudgens MG, Bosch RJ, Coffin JM, Eron JJ, Hazuda DJ, Margolis DM. 2012. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487:482-485. http://dx.doi .org/10.1038/nature11286.
-
(2012)
Nature
, vol.487
, pp. 482-485
-
-
Archin, N.M.1
Liberty, A.L.2
Kashuba, A.D.3
Choudhary, S.K.4
Kuruc, J.D.5
Crooks, A.M.6
Parker, D.C.7
Anderson, E.M.8
Kearney, M.F.9
Strain, M.C.10
Richman, D.D.11
Hudgens, M.G.12
Bosch, R.J.13
Coffin, J.M.14
Eron, J.J.15
Hazuda, D.J.16
Margolis, D.M.17
-
5
-
-
84864934043
-
+ T cells from infected individuals receiving effective antiretroviral therapy
-
+ T cells from infected individuals receiving effective antiretroviral therapy. J. Infect. Dis. 206:765-769. http://dx.doi.org/10.1093 /infdis/jis412.
-
(2012)
J. Infect. Dis.
, vol.206
, pp. 765-769
-
-
Blazkova, J.1
Chun, T.W.2
Belay, B.W.3
Murray, D.4
Justement, J.S.5
Funk, E.K.6
Nelson, A.7
Hallahan, C.W.8
Moir, S.9
Wender, P.A.10
Fauci, A.S.11
-
6
-
-
70449377960
-
Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation
-
Yang HC, Xing S, Shan L, O'Connell K, Dinoso J, Shen A, Zhou Y, Shrum CK, Han Y, Liu JO, Zhang H, Margolick JB, Siliciano RF. 2009. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J. Clin. Invest. 119:3473-3486. http://dx.doi.org/10.1172/JCI39199.
-
(2009)
J. Clin. Invest.
, vol.119
, pp. 3473-3486
-
-
Yang, H.C.1
Xing, S.2
Shan, L.3
O'Connell, K.4
Dinoso, J.5
Shen, A.6
Zhou, Y.7
Shrum, C.K.8
Han, Y.9
Liu, J.O.10
Zhang, H.11
Margolick, J.B.12
Siliciano, R.F.13
-
7
-
-
59449101108
-
+ T cells
-
+ T cells. Blood 113:58-65. http://dx.doi.org/10 .1182/blood-2008-07-168393.
-
(2009)
Blood
, vol.113
, pp. 58-65
-
-
Bosque, A.1
Planelles, V.2
-
8
-
-
63149124261
-
Determinants of the establishment of human immunodeficiency virus type 1 latency
-
Duverger A, Jones J, May J, Bibollet-Ruche F, Wagner FA, Cron RQ, Kutsch O. 2009. Determinants of the establishment of human immunodeficiency virus type 1 latency. J. Virol. 83:3078-3093. http://dx.doi.org /10.1128/JVI.02058-08.
-
(2009)
J. Virol.
, vol.83
, pp. 3078-3093
-
-
Duverger, A.1
Jones, J.2
May, J.3
Bibollet-Ruche, F.4
Wagner, F.A.5
Cron, R.Q.6
Kutsch, O.7
-
10
-
-
84863337769
-
Stimulation of HIV-1- specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation
-
Shan L, Deng K, Shroff NS, Durand CM, Rabi SA, Yang HC, Zhang H, Margolick JB, Blankson JN, Siliciano RF. 2012. Stimulation of HIV-1- specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36:491-501. http://dx.doi.org/10 .1016/j.immuni.2012.01.014.
-
(2012)
Immunity
, vol.36
, pp. 491-501
-
-
Shan, L.1
Deng, K.2
Shroff, N.S.3
Durand, C.M.4
Rabi, S.A.5
Yang, H.C.6
Zhang, H.7
Margolick, J.B.8
Blankson, J.N.9
Siliciano, R.F.10
-
11
-
-
84861393144
-
Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-kB activity
-
Wolschendorf F, Bosque A, Shishido T, Duverger A, Jones J, Planelles V, Kutsch O. 2012. Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-kB activity. J. Virol. 86:4548-4558. http://dx .doi.org/10.1128/JVI.06726-11.
-
(2012)
J. Virol.
, vol.86
, pp. 4548-4558
-
-
Wolschendorf, F.1
Bosque, A.2
Shishido, T.3
Duverger, A.4
Jones, J.5
Planelles, V.6
Kutsch, O.7
-
12
-
-
84873801315
-
An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection
-
Duverger A, Wolschendorf F, Zhang M, Wagner F, Hatcher B, Jones J, Cron RQ, van der Sluis RM, Jeeninga RE, Berkhout B, Kutsch O. 2013. An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection. J. Virol. 87: 2264-2277. http://dx.doi.org/10.1128/JVI.01594-12.
-
(2013)
J. Virol.
, vol.87
, pp. 2264-2277
-
-
Duverger, A.1
Wolschendorf, F.2
Zhang, M.3
Wagner, F.4
Hatcher, B.5
Jones, J.6
Cron, R.Q.7
van der Sluis, R.M.8
Jeeninga, R.E.9
Berkhout, B.10
Kutsch, O.11
-
13
-
-
0027384699
-
In vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells
-
Brunvand MW, Krumm A, Groudine M. 1993. In vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells. Nucleic Acids Res. 21:4824-4829. http://dx.doi.org/10 .1093/nar/21.20.4824.
-
(1993)
Nucleic Acids Res.
, vol.21
, pp. 4824-4829
-
-
Brunvand, M.W.1
Krumm, A.2
Groudine, M.3
-
14
-
-
84874175008
-
Precise maps of RNA polymerase reveal how promoters direct initiation and pausing
-
Kwak H, Fuda NJ, Core LJ, Lis JT. 2013. Precise maps of RNA polymerase reveal how promoters direct initiation and pausing. Science 339:950- 953. http://dx.doi.org/10.1126/science.1229386.
-
(2013)
Science
, vol.339
-
-
Kwak, H.1
Fuda, N.J.2
Core, L.J.3
Lis, J.T.4
-
15
-
-
84876842759
-
Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells
-
Danko CG, Hah N, Luo X, Martins AL, Core L, Lis JT, Siepel A, Kraus WL. 2013. Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol. Cell 50:212-222. http://dx.doi.org/10.1016/j.molcel.2013.02.015.
-
(2013)
Mol. Cell
, vol.50
, pp. 212-222
-
-
Danko, C.G.1
Hah, N.2
Luo, X.3
Martins, A.L.4
Core, L.5
Lis, J.T.6
Siepel, A.7
Kraus, W.L.8
-
16
-
-
78149477660
-
Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation
-
Gilchrist DA, Dos Santos G, Fargo DC, Xie B, Gao Y, Li L, Adelman K. 2010. Pausing of RNA polymerase II disrupts DNA-specified nucleosome organization to enable precise gene regulation. Cell 143:540-551. http: //dx.doi.org/10.1016/j.cell.2010.10.004.
-
(2010)
Cell
, vol.143
, pp. 540-551
-
-
Gilchrist, D.A.1
Dos Santos, G.2
Fargo, D.C.3
Xie, B.4
Gao, Y.5
Li, L.6
Adelman, K.7
-
17
-
-
40749092840
-
The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity
-
Klatt A, Zhang Z, Kalantari P, Hankey PA, Gilmour DS, Henderson AJ. 2008. The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity. J. Immunol. 180:1670-1677.
-
(2008)
J. Immunol
, vol.180
, pp. 1670-1677
-
-
Klatt, A.1
Zhang, Z.2
Kalantari, P.3
Hankey, P.A.4
Gilmour, D.S.5
Henderson, A.J.6
-
18
-
-
34447122581
-
Negative elongation factor NELF represses human immunodeficiency virus transcription by pausing the RNA polymerase II complex
-
Zhang Z, Klatt A, Gilmour DS, Henderson AJ. 2007. Negative elongation factor NELF represses human immunodeficiency virus transcription by pausing the RNA polymerase II complex. J. Biol. Chem. 282:16981- 16988. http://dx.doi.org/10.1074/jbc.M610688200.
-
(2007)
J. Biol. Chem.
, vol.282
-
-
Zhang, Z.1
Klatt, A.2
Gilmour, D.S.3
Henderson, A.J.4
-
19
-
-
33747605357
-
Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency
-
Kim YK, Bourgeois CF, Pearson R, Tyagi M, West MJ, Wong J, Wu SY, Chiang CM, Karn J. 2006. Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency. EMBO J. 25: 3596-3604. http://dx.doi.org/10.1038/sj.emboj.7601248.
-
(2006)
EMBO J.
, vol.25
, pp. 3596-3604
-
-
Kim, Y.K.1
Bourgeois, C.F.2
Pearson, R.3
Tyagi, M.4
West, M.J.5
Wong, J.6
Wu, S.Y.7
Chiang, C.M.8
Karn, J.9
-
20
-
-
37149031062
-
CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency
-
Tyagi M, Karn J. 2007. CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J. 26:4985-4995. http://dx.doi .org/10.1038/sj.emboj.7601928.
-
(2007)
EMBO J.
, vol.26
, pp. 4985-4995
-
-
Tyagi, M.1
Karn, J.2
-
21
-
-
82455219436
-
Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency
-
Rafati H, Parra M, Hakre S, Moshkin Y, Verdin E, Mahmoudi T. 2011. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency. PLoS Biol. 9:e1001206. http://dx.doi.org/10.1371/journal .pbio.1001206.
-
(2011)
PLoS Biol.
, vol.9
-
-
Rafati, H.1
Parra, M.2
Hakre, S.3
Moshkin, Y.4
Verdin, E.5
Mahmoudi, T.6
-
22
-
-
60349089645
-
Nucleosome positioning and gene regulation: advances through genomics
-
Jiang C, Pugh BF. 2009. Nucleosome positioning and gene regulation: advances through genomics. Nat. Rev. Genet. 10:161-172. http://dx.doi .org/10.1038/nrg2522.
-
(2009)
Nat. Rev. Genet.
, vol.10
, pp. 161-172
-
-
Jiang, C.1
Pugh, B.F.2
-
23
-
-
77957883572
-
Gene regulation by nucleosome positioning
-
Bai L, Morozov AV. 2010. Gene regulation by nucleosome positioning. Trends Genet. 26:476-483. http://dx.doi.org/10.1016/j.tig.2010.08.003.
-
(2010)
Trends Genet.
, vol.26
, pp. 476-483
-
-
Bai, L.1
Morozov, A.V.2
-
24
-
-
84866161281
-
Selected drugs with reported secondary celldifferentiating capacity prime latent HIV-1 infection for reactivation
-
Shishido T, Wolschendorf F, Duverger A, Wagner F, Kappes J, Jones J, Kutsch O. 2012. Selected drugs with reported secondary celldifferentiating capacity prime latent HIV-1 infection for reactivation. J. Virol. 86:9055-9069. http://dx.doi.org/10.1128/JVI.00793-12.
-
(2012)
J. Virol.
, vol.86
, pp. 9055-9069
-
-
Shishido, T.1
Wolschendorf, F.2
Duverger, A.3
Wagner, F.4
Kappes, J.5
Jones, J.6
Kutsch, O.7
-
25
-
-
0036337415
-
Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency
-
Kutsch O, Benveniste EN, Shaw GM, Levy DN. 2002. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76:8776-8786. http://dx.doi.org/10.1128 /JVI.76.17.8776-8786.2002.
-
(2002)
J. Virol.
, vol.76
, pp. 8776-8786
-
-
Kutsch, O.1
Benveniste, E.N.2
Shaw, G.M.3
Levy, D.N.4
-
26
-
-
34247585019
-
High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds
-
Jones J, Rodgers J, Heil M, May J, White L, Maddry JA, Fletcher TM, III, Shaw GM, Hartman JL, IV, Kutsch O. 2007. High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds. Assay Drug Dev. Technol. 5:181-189. http://dx.doi.org/10.1089 /adt.2006.040.
-
(2007)
Assay Drug Dev. Technol.
, vol.5
, pp. 181-189
-
-
Jones, J.1
Rodgers, J.2
Heil, M.3
May, J.4
White, L.5
Maddry, J.A.6
Fletcher, T.M.7
Shaw, G.M.8
Hartman, J.L.9
Kutsch, O.10
-
27
-
-
78651509617
-
Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells
-
Bosque A, Planelles V. 2011. Studies of HIV-1 latency in an ex vivo model that uses primary central memory T cells. Methods 53:54-61. http://dx .doi.org/10.1016/j.ymeth.2010.10.002.
-
(2011)
Methods
, vol.53
, pp. 54-61
-
-
Bosque, A.1
Planelles, V.2
-
28
-
-
84868544558
-
CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90
-
Breuer D, Kotelkin A, Ammosova T, Kumari N, Ivanov A, Ilatovskiy AV, Beullens M, Roane PR, Bollen M, Petukhov MG, Kashanchi F, Nekhai S. 2012. CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90. Retrovirology 9:94. http://dx.doi.org/10.1186/1742 -4690-9-94.
-
(2012)
Retrovirology
, vol.9
, pp. 94
-
-
Breuer, D.1
Kotelkin, A.2
Ammosova, T.3
Kumari, N.4
Ivanov, A.5
Ilatovskiy, A.V.6
Beullens, M.7
Roane, P.R.8
Bollen, M.9
Petukhov, M.G.10
Kashanchi, F.11
Nekhai, S.12
-
29
-
-
77952932797
-
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
-
Guendel I, Agbottah ET, Kehn-Hall K, Kashanchi F. 2010. Inhibition of human immunodeficiency virus type-1 by cdk inhibitors. AIDS Res. Ther. 7:7. http://dx.doi.org/10.1186/1742-6405-7-7.
-
(2010)
AIDS Res. Ther.
, vol.7
, pp. 7
-
-
Guendel, I.1
Agbottah, E.T.2
Kehn-Hall, K.3
Kashanchi, F.4
-
30
-
-
33751195065
-
Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription
-
Ammosova T, Berro R, Jerebtsova M, Jackson A, Charles S, Klase Z, Southerland W, Gordeuk VR, Kashanchi F, Nekhai S. 2006. Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription. Retrovirology 3:78. http://dx.doi.org/10.1186/1742-4690-3-78.
-
(2006)
Retrovirology
, vol.3
, pp. 78
-
-
Ammosova, T.1
Berro, R.2
Jerebtsova, M.3
Jackson, A.4
Charles, S.5
Klase, Z.6
Southerland, W.7
Gordeuk, V.R.8
Kashanchi, F.9
Nekhai, S.10
-
31
-
-
41149093037
-
Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase
-
Pierce AC, Jacobs M, Stuver-Moody C. 2008. Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase. J. Med. Chem. 51: 1972-1975. http://dx.doi.org/10.1021/jm701248t.
-
(2008)
J. Med. Chem.
, vol.51
, pp. 1972-1975
-
-
Pierce, A.C.1
Jacobs, M.2
Stuver-Moody, C.3
-
32
-
-
2142814315
-
Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription
-
Kutsch O, Levy DN, Bates PJ, Decker J, Kosloff BR, Shaw GM, Priebe W, Benveniste EN. 2004. Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription. Antimicrob. Agents Chemother. 48:1652-1663. http://dx.doi.org/10.1128/AAC.48.5.1652-1663 .2004.
-
(2004)
Antimicrob. Agents Chemother.
, vol.48
, pp. 1652-1663
-
-
Kutsch, O.1
Levy, D.N.2
Bates, P.J.3
Decker, J.4
Kosloff, B.R.5
Shaw, G.M.6
Priebe, W.7
Benveniste, E.N.8
-
33
-
-
33749845927
-
A high-throughput drug screening system for HIV-1 transcription inhibitors
-
Kempf MC, Jones J, Heil ML, Kutsch O. 2006. A high-throughput drug screening system for HIV-1 transcription inhibitors. J. Biomol. Screen 11:807-815. http://dx.doi.org/10.1177/1087057106290292.
-
(2006)
J. Biomol. Screen
, vol.11
, pp. 807-815
-
-
Kempf, M.C.1
Jones, J.2
Heil, M.L.3
Kutsch, O.4
-
34
-
-
0025004457
-
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells
-
Kinter AL, Poli G, Maury W, Folks TM, Fauci AS. 1990. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J. Virol. 64:4306-4312.
-
(1990)
J. Virol.
, vol.64
, pp. 4306-4312
-
-
Kinter, A.L.1
Poli, G.2
Maury, W.3
Folks, T.M.4
Fauci, A.S.5
-
35
-
-
84866842026
-
Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro
-
DeChristopher BA, Loy BA, Marsden MD, Schrier AJ, Zack JA, Wender PA. 2012. Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro. Nat. Chem. 4:705-710. http://dx.doi.org/10.1038/nchem.1395.
-
(2012)
Nat. Chem.
, vol.4
, pp. 705-710
-
-
DeChristopher, B.A.1
Loy, B.A.2
Marsden, M.D.3
Schrier, A.J.4
Zack, J.A.5
Wender, P.A.6
-
36
-
-
84880351418
-
Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo
-
Beans EJ, Fournogerakis D, Gauntlett C, Heumann LV, Kramer R, Marsden MD, Murray D, Chun TW, Zack JA, Wender PA. 2013. Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo. Proc. Natl. Acad. Sci. U. S. A. 110:11698- 11703. http://dx.doi.org/10.1073/pnas.1302634110.
-
(2013)
Proc. Natl. Acad. Sci. U. S. A.
, vol.110
-
-
Beans, E.J.1
Fournogerakis, D.2
Gauntlett, C.3
Heumann, L.V.4
Kramer, R.5
Marsden, M.D.6
Murray, D.7
Chun, T.W.8
Zack, J.A.9
Wender, P.A.10
-
37
-
-
0033600851
-
ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kB
-
Yang X, Chen Y, Gabuzda D. 1999. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kB. J. Biol. Chem. 274:27981-27988. http://dx .doi.org/10.1074/jbc.274.39.27981.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 27981-27988
-
-
Yang, X.1
Chen, Y.2
Gabuzda, D.3
-
38
-
-
0032483991
-
Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28
-
Li-Weber M, Giasi M, Krammer PH. 1998. Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J. Biol. Chem. 273:32460-32466. http://dx.doi.org /10.1074/jbc.273.49.32460.
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 32460-32466
-
-
Li-Weber, M.1
Giasi, M.2
Krammer, P.H.3
-
39
-
-
0033607804
-
Functional disparity of distinct CD28 response elements toward mitogenic responses
-
Civil A, Rensink I, Aarden LA, Verweij CL. 1999. Functional disparity of distinct CD28 response elements toward mitogenic responses. J. Biol. Chem. 274:34369-34374. http://dx.doi.org/10.1074/jbc.274.48.34369.
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 34369-34374
-
-
Civil, A.1
Rensink, I.2
Aarden, L.A.3
Verweij, C.L.4
-
40
-
-
0034030611
-
Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G
-
Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B. 2000. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J. Virol. 74:3740-3751. http://dx.doi.org/10.1128 /JVI.74.8.3740-3751.2000.
-
(2000)
J. Virol.
, vol.74
, pp. 3740-3751
-
-
Jeeninga, R.E.1
Hoogenkamp, M.2
Armand-Ugon, M.3
de Baar, M.4
Verhoef, K.5
Berkhout, B.6
-
41
-
-
0032539890
-
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
-
Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA, Marks PA. 1998. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. Proc. Natl. Acad. Sci. U. S. A. 95:3003-3007. http://dx.doi.org/10.1073/pnas.95.6.3003.
-
(1998)
Proc. Natl. Acad. Sci. U. S. A.
, vol.95
, pp. 3003-3007
-
-
Richon, V.M.1
Emiliani, S.2
Verdin, E.3
Webb, Y.4
Breslow, R.5
Rifkind, R.A.6
Marks, P.A.7
-
42
-
-
1542588471
-
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation
-
Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks PA. 1996. Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 93:5705-5708. http://dx.doi.org/10.1073/pnas.93.12 .5705.
-
(1996)
Proc. Natl. Acad. Sci. U. S. A.
, vol.93
, pp. 5705-5708
-
-
Richon, V.M.1
Webb, Y.2
Merger, R.3
Sheppard, T.4
Jursic, B.5
Ngo, L.6
Civoli, F.7
Breslow, R.8
Rifkind, R.A.9
Marks, P.A.10
-
43
-
-
84866149019
-
Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells
-
Zhang M, Clausell A, Robinson T, Yin J, Chen E, Johnson L, Weiss G, Sabbaj S, Lowe RM, Wagner FH, Goepfert PA, Kutsch O, Cron RQ. 2012. Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells. J. Immunol. 189:2746-2757. http://dx.doi.org/10.4049/jimmunol.1103129.
-
(2012)
J. Immunol.
, vol.189
, pp. 2746-2757
-
-
Zhang, M.1
Clausell, A.2
Robinson, T.3
Yin, J.4
Chen, E.5
Johnson, L.6
Weiss, G.7
Sabbaj, S.8
Lowe, R.M.9
Wagner, F.H.10
Goepfert, P.A.11
Kutsch, O.12
Cron, R.Q.13
-
44
-
-
79959476700
-
The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling
-
Dar AC, Shokat KM. 2011. The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling. Annu. Rev. Biochem. 80:769- 795. http://dx.doi.org/10.1146/annurev-biochem-090308-173656.
-
(2011)
Annu. Rev. Biochem.
, vol.80
-
-
Dar, A.C.1
Shokat, K.M.2
-
45
-
-
13444251304
-
The serine/threonine kinase Pim-1
-
Bachmann M, Moroy T. 2005. The serine/threonine kinase Pim-1. Int. J. Biochem. Cell Biol. 37:726-730. http://dx.doi.org/10.1016/j.biocel.2004 .11.005.
-
(2005)
Int. J. Biochem. Cell Biol.
, vol.37
, pp. 726-730
-
-
Bachmann, M.1
Moroy, T.2
-
46
-
-
0029670723
-
Pim-1 protooncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1
-
Wingett D, Long A, Kelleher D, Magnuson NS. 1996. Pim-1 protooncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J. Immunol. 156:549-557.
-
(1996)
J. Immunol
, vol.156
, pp. 549-557
-
-
Wingett, D.1
Long, A.2
Kelleher, D.3
Magnuson, N.S.4
-
47
-
-
77949540609
-
Pim-1 controls NF-kB signalling by stabilizing RelA/p65
-
Nihira K, Ando Y, Yamaguchi T, Kagami Y, Miki Y, Yoshida K. 2010. Pim-1 controls NF-kB signalling by stabilizing RelA/p65. Cell Death Differ. 17:689-698. http://dx.doi.org/10.1038/cdd.2009.174.
-
(2010)
Cell Death Differ.
, vol.17
, pp. 689-698
-
-
Nihira, K.1
Ando, Y.2
Yamaguchi, T.3
Kagami, Y.4
Miki, Y.5
Yoshida, K.6
-
48
-
-
0037083465
-
Cutting edge: transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase
-
Rainio EM, Sandholm J, Koskinen PJ. 2002. Cutting edge: transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase. J. Immunol. 168:1524-1527.
-
(2002)
J. Immunol
, vol.168
, pp. 1524-1527
-
-
Rainio, E.M.1
Sandholm, J.2
Koskinen, P.J.3
-
49
-
-
0025773849
-
Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat
-
Li C, Lai CF, Sigman DS, Gaynor RB. 1991. Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. U. S. A. 88:7739-7743. http://dx.doi.org/10.1073/pnas.88.17.7739.
-
(1991)
Proc. Natl. Acad. Sci. U. S. A.
, vol.88
, pp. 7739-7743
-
-
Li, C.1
Lai, C.F.2
Sigman, D.S.3
Gaynor, R.B.4
-
50
-
-
0025362352
-
Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner
-
Schmidt A, Hennighausen L, Siebenlist U. 1990. Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner. J. Virol. 64:4037-4041.
-
(1990)
J. Virol
, vol.64
, pp. 4037-4041
-
-
Schmidt, A.1
Hennighausen, L.2
Siebenlist, U.3
-
51
-
-
0023821516
-
Identification of a putative regulator of early T cell activation genes
-
Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR. 1988. Identification of a putative regulator of early T cell activation genes. Science 241:202-205. http://dx.doi.org/10.1126/science.3260404.
-
(1988)
Science
, vol.241
, pp. 202-205
-
-
Shaw, J.P.1
Utz, P.J.2
Durand, D.B.3
Toole, J.J.4
Emmel, E.A.5
Crabtree, G.R.6
-
52
-
-
3242792513
-
Reciprocal regulation of the nuclear factor of activated T cells and HIV-1
-
Pessler F, Cron RQ. 2004. Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes Immun. 5:158-167. http://dx.doi.org /10.1038/sj.gene.6364047.
-
(2004)
Genes Immun.
, vol.5
, pp. 158-167
-
-
Pessler, F.1
Cron, R.Q.2
-
53
-
-
0034011644
-
NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells
-
Cron RQ, Bartz SR, Clausell A, Bort SJ, Klebanoff SJ, Lewis DB. 2000. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells. Clin. Immunol. 94:179-191. http://dx.doi.org/10.1006/clim.1999.4831.
-
(2000)
Clin. Immunol.
, vol.94
, pp. 179-191
-
-
Cron, R.Q.1
Bartz, S.R.2
Clausell, A.3
Bort, S.J.4
Klebanoff, S.J.5
Lewis, D.B.6
-
54
-
-
0030939152
-
The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells
-
Kinoshita S, Su L, Amano M, Timmerman LA, Kaneshima H, Nolan GP. 1997. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6:235-244. http://dx .doi.org/10.1016/S1074-7613(00)80326-X.
-
(1997)
Immunity
, vol.6
, pp. 235-244
-
-
Kinoshita, S.1
Su, L.2
Amano, M.3
Timmerman, L.A.4
Kaneshima, H.5
Nolan, G.P.6
-
55
-
-
79953304038
-
Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2
-
Ahangarani RR, Janssens W, Carlier V, Vanderelst L, Vandendriessche T, Chuah M, Jacquemin M, Saint-Remy JM. 2011. Retroviral vectors induce epigenetic chromatin modifications and IL-10 production in transduced B cells via activation of toll-like receptor 2. Mol. Ther. 19:711- 722. http://dx.doi.org/10.1038/mt.2010.275.
-
(2011)
Mol. Ther.
, vol.19
-
-
Ahangarani, R.R.1
Janssens, W.2
Carlier, V.3
Vanderelst, L.4
Vandendriessche, T.5
Chuah, M.6
Jacquemin, M.7
Saint-Remy, J.M.8
|